Research to make early detection of Alzheimer’s disease more accessible

By combining a simple blood test with a cognitive exam and demographics, researchers at UNT Health Science Center were able to accurately detect Alzheimer’s disease, even in its very early stages.

The research could lead to a rapid, accurate and cost-effective way to screen for Alzheimer’s disease, said Dr. Sid O’Bryant, Interim Director of the Institute for Aging and Alzheimer’s Disease Research and one of four authors of the study in the Journal of Alzheimer’s Disease.

"We’re talking about one finger stick and a short cognitive test," Dr. O’Bryant said.  "Every patient 60 and older could get it once a year from their primary care doctor."

For the study, only two blood biomarkers were screened. The Clock Drawing Test, which requires participants to place the hands and numbers on a predetermined time, was used for the cognitive exam.

The combination of tests could make early detection more accessible to the growing population of people at risk for Alzheimer’s disease. Currently 5.2 million people have Alzheimer’s disease, but that number is expected to triple by 2050.

The prevalence of Alzheimer’s disease has led to a heightened interest in finding an accurate tool for early detection. Earlier treatment helps preserve function and leads to better outcomes, Dr. O’Bryant said.

The model could be used to screen for the disease before more expensive, time-consuming and invasive procedures are considered.

"Instead of a comprehensive dementia exam, which takes two hours, this entire process can be done in less than 10 minutes," Dr. O’Bryant said. "Then if you get a positive result, you can do a full blown blood test and brain scan."

It also would make screening available to more people.

"The problem now is there are far more elders who should be screened for cognitive loss than there is capacity," Dr. O’Bryant said. "This is cost effective, time effective, and it won’t over-burden the health care system."

The financial burden for Alzheimer’s disease is estimated at $200 billion but that could reach $1.1 trillion by 2050.

Dr. James Hall, Professor of Psychiatry and Behavioral Health also participated in the research. Melissa Edwards, a PhD student in the psychology department at UNT was lead author on the study.

Recent News

1
  • Our People
|Sep 17, 2024

HSC College of Pharmacy scientists named in World’s Top 2% in latest edition from Stanford University/Elsevier

Stanford University and Elsevier have released the sixth edition of their World’s Top 2% of Scientists List, which features three faculty members from The University of North Texas Health Science Center at Fort Worth's College of Pharmacy. The rankings were based on data compiled through 2022, ...
May 29, 2020.
  • Community
|Sep 13, 2024

Important update on Willed Body Program

We have become aware of issues within our Willed Body Program, and that failures existed in its management and oversight. The program has fallen short of the standards of respect, care, and professionalism that we demand. The University of North Texas Health Science Center at Fort Worth extends its ...
Tammy Wheat
  • Patient Care
|Sep 12, 2024

New aquatic exercise program at ForeverFit offers hope, healing for cancer patients

The University of North Texas Health Science Center at Fort Worth’s ForeverFit clinic, a no-cost exercise space exclusively for cancer patients and survivors, now offers a free aquatic exercise program. The innovative program harnesses the benefits of hydrotherapy to provide a gentle, yet p...
Aaic
  • Research
|Sep 10, 2024

TCOM faculty member participates in the elite Butler-Williams Scholars Program hosted by NIA

After 10 years as a clinician, Lubnaa Abdullah, Psy.D, ABPP, was ready for a change. Her career as a clinical psychologist with specialty training in neuropsychology was rewarding, but she wanted something new and has found it at the Texas College of Osteopathic Medicine at The University of North T...